SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 157 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 3.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $720,446 | +21.9% | 750,465 | -4.8% | 0.77% | +23.4% |
Q1 2023 | $590,980 | +103.5% | 787,973 | 0.0% | 0.62% | +124.5% |
Q4 2022 | $290,368 | -14.3% | 787,973 | 0.0% | 0.28% | -35.0% |
Q3 2022 | $339,000 | -44.9% | 787,973 | 0.0% | 0.43% | -44.4% |
Q2 2022 | $615,000 | -59.5% | 787,973 | -33.1% | 0.77% | -43.9% |
Q1 2022 | $1,518,000 | +1.5% | 1,177,115 | 0.0% | 1.37% | +8.2% |
Q4 2021 | $1,495,000 | -58.6% | 1,177,115 | -29.0% | 1.27% | -60.1% |
Q3 2021 | $3,612,000 | -41.6% | 1,656,815 | +0.5% | 3.18% | -18.3% |
Q2 2021 | $6,185,000 | +18.6% | 1,649,315 | +3.1% | 3.89% | +22.4% |
Q1 2021 | $5,214,000 | -0.7% | 1,599,449 | +3.9% | 3.18% | +20.8% |
Q4 2020 | $5,251,000 | -12.9% | 1,539,949 | +4.2% | 2.63% | -35.4% |
Q3 2020 | $6,027,000 | +57.2% | 1,477,212 | +30.2% | 4.08% | +81.9% |
Q2 2020 | $3,834,000 | +140.5% | 1,134,271 | +65.8% | 2.24% | +117.2% |
Q1 2020 | $1,594,000 | +1362.4% | 684,189 | +2683.9% | 1.03% | +647.8% |
Q4 2016 | $109,000 | -5.2% | 24,577 | 0.0% | 0.14% | -13.8% |
Q3 2016 | $115,000 | – | 24,577 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 787,973 | $615,000 | 0.77% |
CM Management, LLC | 600,000 | $468,000 | 0.50% |
ARMISTICE CAPITAL, LLC | 17,100,000 | $13,338,000 | 0.23% |
Sargent Investment Group, LLC | 614,600 | $479,000 | 0.15% |
Ergoteles LLC | 744,275 | $581,000 | 0.02% |
Sonora Investment Management Group, LLC | 103,000 | $80,000 | 0.01% |
CAXTON ASSOCIATES LP | 107,135 | $84,000 | 0.01% |
MCDONALD PARTNERS LLC | 42,570 | $33,000 | 0.01% |
Pinz Capital Management, LP | 15,600 | $12,000 | 0.01% |
D. E. Shaw & Co., Inc. | 8,051,858 | $6,281,000 | 0.01% |